Date: 3rd October 2019
Gene editing goes digital, as Inscripta launch their new automated platform for CRISPR-mediated genome engineering.
CRISPR technology is a hot topic in synthetic biology. Whilst the hype surrounding its potential has been huge, the reality is starting to be realised with a vast range of life-changing CRISPR-based applications coming into focus on a regular basis.
To name but a few…
Inscripta have announced this week the launch of the world’s first fully automated benchtop instrument bringing genome-scale engineering to the lab.
Harnessing the power of CRISPR technology, they have created a CRISPR-mediated engineering platform. It enables the user to precisely engineer millions of microbial libraries containing the full breadth and scope of possible edit types, in one experiment through a fully automated workflow.
The Onyx™ platform is hoped to empower the researcher, transforming the capabilities of design, engineering, evaluation and tracking results of genome editing experiments. It will connect these processes in one workflow and encompass it into the scientists own lab. It is likely to allow multiple hypotheses to be tested in parallel, and reduce the time and cost associated with the optimisation of complex gene editing methods.
Early adopters have been granted access to Onyx™ in a range of fields
The Onyx™ platform sees synthetic biology meet lab automation. For the researcher this offers an exciting advancement in CRISPR technology development, where we have recently seen the drive towards multi-gene editing platforms, such as CRISPR activation in bacterial factories, and Lightning GTR-CRISPR as a method of multiplexing gene editing.
Whilst these methods offered substantial advancement, this fully automated digital engineering platform takes the technology to yet another level and it will be interesting to see the dynamics of its uptake.
For more information please read the press release.